Entera Bio (ENTX) Research & Development (2019 - 2026)
Entera Bio's Research & Development was $3.2 million in Q2 2026, up 110.6% from $1.52 million a year earlier and up 42.2% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Research & Development (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Entera Bio's Research & Development was $8.81 million through Jun 30, 2026, up 65.6% year-over-year; for FY2025, it came in at $6 million, up 33.5% from FY2024.
- Research & Development shows a five-year compound annual growth rate of -1.2% (FY2020 to FY2025).
- In earlier years, Research & Development was $4.5 million in FY2024 (-0.2%), $4.51 million in FY2023 (-22.9%), $5.85 million in FY2022 (-13.6%) and $6.77 million in FY2021 (+6.1%).
- The Q2 2026 figure marks the highest quarterly Research & Development in data going back to Q2 2020.
- Compared with a year earlier, Research & Development has increased for eight straight quarters, with growth averaging 48.2% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q2 2026 (growth of 110.6%); the worst was Q4 2022 (a decline of 49.0%).
- Per Business Quant data, ENTX's Research & Development in the three quarters before Q2 2026 was $2.25 million (Q1 2026), $1.72 million (Q4 2025) and $1.64 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Entera Bio | 132.59 Mn | 101.46 Mn | - | 3.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.20 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.64 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.09 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.21 Mn |
| Mar 31, 2023 | 931,000.00 |
| Dec 31, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.65 Mn |
| Sep 30, 2021 | 1.77 Mn |
API Access
Entera Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();